From SLEEPBUTAWHILE.COM:

“[0069] In another aspect, the invention provides a method for propagating the hEbola virus in host cells comprising infecting the host cells with an inventive isolated West African hEbola virus described above, culturing the host cells to allow the virus to multiply, and harvesting the resulting virions.” – from the U.S. / CDC Patent,  page 16

You can view the patent for a variant of Ebola, owned by the U.S. and CDC HERE.  All news articles listed in this post are also archived HERE, in case they are memory-holed.

[Updated 16 Sept 2014] – The end game is beginning to take shape, as we see the USG is now sending 3000 MILITARY troops into Liberia to “combat” the spread of the virus.  As you read this post you will see why that is EXACTLY what we would expect from this false-flag event.

[Updated 28 Aug 2014] – Scientific American has published an interview with the Doctor at Emory who treated the two Ebola victims brought back the US and you can read it here (Archived here).  In addition, USA Today reports that a CDC worker who was exposed to Ebola has been flown back to the US but NOT ISOLATED, and will be allowed to return to work because he “shows no symptoms”, but hey, doesn’t it take 21 days for Ebola to show up?

[Updated 22 Aug 2014] – Although you wont find this very many places, Dr Brantley received a blood transfusion from a teenage patient (Story archived HERE) who had Ebola and then was cured.  Why HE didn’t mention this during his discharge press conference is a mystery to me.  Also, if this man is a Christian, why isn’t he making sure, through the media, that this teenager is in safe hands, and not being used as a guinea pig in some freakish hell of experimentation?  After all, it’s just as likely this teenager is the real reason for his remarkable recovery.  In the same report on Forbes website it was reported that both Brantley and the other American flown out of Liberia have been back in the United States LESS THAN 21 days before their discharge and that “…While I was livetweeting the press conference, Kent State University infectious disease epidemiologist, Dr. Tara C. Smith, asked me if Brantly was counseled about having sex since the virus could be carried in semen for a time after recovery. One of the reporters in attendance asked that question and Ribner referred to CDC guidelines. However, I’m unable to find a resource for these post-discharge recommendations, such as using condoms or avoiding sex entirely…” – It is important to note that the virus can be in the system for up to 21 days without showing any symptoms

[Updated13 Aug 2014] – From the TKM site:

Joint Project Manager Medical Countermeasure Systems (JPM-MCS) U.S. Department of Defense (DoD)

[Updated 07 Aug 2014] -Although the MSM keeps saying that Ebola is not transmitted by air (i.e., the World Health Organization is quoted in this AP story), the BBC reported on 15 Nov 2012, that “…Canadian scientists have shown that the deadliest form of the ebola virus could be transmitted by air between species…In their experiments, the pigs carrying the virus were housed in pens with the monkeys in close proximity but separated by a wire barrier. After eight days, some of the macaques were showing clinical signs typical of ebola and were euthanised…One possibility is that the monkeys became infected by inhaling large aerosol droplets produced from the respiratory tracts of the pigs…”.  The story also included links to the actual scientific study, which you can view HERE

It is interesting that Liberia is where this strain of Ebola has “broke out”,

["Liberia, where the death toll has risen to 282 people, is a ground zero for the catastrophic outbreak." -- ABC News]

since it was formed by the U.S. government and one of the worst warlords of that country, Charles Taylor, was proven to be a CIA agent…And of course, we have this little tidbit from the AP dated Aug 5, 2014:

“…Brantly and Writebol were both infected despite taking precautions as they treated Ebola patients in West Africa, where the virus has been spreading faster than governments can contain it, killing nearly 900 people so far.

The treatment, called ZMapp, was developed with U.S. military funding by a San Diego company, using antibodies harvested from lab animals that had been injected with parts of the Ebola virus. Tobacco plants in Kentucky are being used to make the treatment....The U.S. Defense Threat Reduction Agency announced last month that it is providing more funding to speed the drug’s development…”

And let us not forget, President Obama conveniently just hosted African leaders at the very moment this “crisis” explodes across American media concerning the two missionaries contracting Ebola…

[Updated 06 Aug 2014] – In a twist that is a little murky at best, we find that the “cocktail” given to the two Americans who just returned from Africa was referred by a person working with … the Nuclear, Biological, Chemical, Radiation (NCBR) Defense team in AFRICA.  From ABC News (dated 04 Aug 2014 and archived HERE), we read:

“Desperate to save the American Ebola patients in Liberia, Samaritan’s Purse started researching experimental treatments last week, according to an official at the National Institutes of Health.  The organization called the Centers for Disease Control and Prevention, which referred it to an NIH employee deployed in Africa who would be familiar with the treatments.  “She was able to answer some questions and referred them to appropriate company and embassy contacts to pursue their interest in obtaining experimental product,” said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.  He added that the NIH employee was not working in any official capacity for the NIH at the time. She was working for a team led by CDC and the Defense Threat Reduction Agency.“

Huh?  Who is the Defense Threat Reduction Agency?  From their own web-page, we find:

” DTRA is the U.S. Department of Defense’s official Combat Support Agency for countering weapons of mass destruction. Our people are Subject Matter Experts on WMD, and we address the entire spectrum of chemical, biological, radiological, nuclear and high yield explosive threats. DTRA’s programs include basic science research and development, operational support to U.S. warfighters on the front line, and an in-house WMD think tank that aims to anticipate and mitigate future threats long before they have a chance to harm the United States and our allies. SCC-WMD, the U.S. Strategic Command Center for Combating Weapons of Mass Destruction, synchronizes Combating Weapons of Mass Destruction efforts across our military’s geographic commands and leverages the people, programs and interagency relationships of DTRA at a strategic level. We work with the military services, other elements of the United States government, and countries across the planet on counterproliferation, nonproliferation and WMD reduction issues with one goal in mind: Making the World Safer.

I don’t know why this agency has people working in Africa, unless MAYBE they are using Ebola as a testing ground for either antidotes or weaponizing?  Either way, there’s much more to this story than what the MSM is providing…and who is funding ZMAPP, the drug cocktail that was used on the two missionaries (who, by the way, made recovery that some are saying defies logic)?  Why, the very same DTRA! In Newsweek, updated 04 Aug 2014, we read:

“UPDATE, Aug. 4, 2014 2:05 PM: The two Americans stricken with Ebola, Dr. Kent Brantly and Nancy Writebol, have been given an experimental treatment for the virus, reports CNN. The treatment is called ZMapp, and was developed by the biotech from Mapp Biopharmaceutical Inc. According to CNN, the patents were “told that this treatment had never been tried before in a human being, but had shown promise in small experiments with monkeys.” Reportedly within an hour of receiving the medication, Brantly’s symptoms improved dramatically. Writebol’s first dose did not have immediate effect, but the second dose resulted in “significant improvement.” Five days ago, the Defense Threat Reduction Agency awarded additional funding to Mapp Biopharmaceutical for the “promising results” the ZMapp treatment had shown.”

And lastly, from Yahoo News:  “Two American aid workers infected with Ebola are getting an experimental drug so novel it has never been tested for safety in humans and was only identified as a potential treatment earlier this year, thanks to a longstanding research program by the U.S. government and the military.”  Why, of course, nothing to fear here…

I am re-posting this outstanding commentary from Natural News (and thanks very much to my wife, for pointing this out to me)…It is even more dangerous a situation when you realize a setup for possible Ebola release was put in motion with the Anthrax scare in the CDC a few weeks ago, meant to show us “sheep” that the CDC has a precedent for accidental exposure / release…reading this, and understanding the implications of the U.S. / CDC claiming to have invented Ebola, it is clear why they are bringing the Ebola patients back to the CDC…just harvesting more deadly diseases for their “arsenal” AND set up manufacturers who will want to reap profits for their Ebola “cure”…

Reposted from Natural News (and archived here)

naturalnews.com printable article

Originally published August 3 2014

Why does the CDC own a patent on Ebola ‘invention?’

by Mike Adams, the Health Ranger, NaturalNews Editor

(NaturalNews) The U.S. Centers for Disease Control owns a patent on a particular strain of Ebola known as “EboBun.” It’s patent No. CA2741523A1 and it was awarded in 2010. You can view it here. (Thanks to Natural News readers who found this and brought it to our attention.)

Patent applicants are clearly described on the patent as including:

The Government Of The United States Of America As Represented By The Secretary, Department Of Health & Human Services, Center For Disease Control.

The patent summary says, “The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention (“CDC”; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291.”

It goes on to state, “The present invention is based upon the isolation and identification of a new human Ebola virus species, EboBun. EboBun was isolated from the patients suffering from hemorrhagic fever in a recent outbreak in Uganda.”

It’s worth noting, by the way, that EboBun is not the same variant currently believed to be circulating in West Africa. Clearly, the CDC needs to expand its patent portfolio to include more strains, and that may very well be why American Ebola victims have been brought to the United States in the first place. Read more below and decide for yourself…

Harvesting Ebola from victims to file patents

From the patent description on the EboBun virus, we know that the U.S. government:

1) Extracts Ebola viruses from patients.

2) Claims to have “invented” that virus.

3) Files for monopoly patent protection on the virus.

To understand why this is happening, you have to first understand what a patent really is and why it exists. A patent is a government-enforced monopoly that is exclusively granted to persons or organizations. It allows that person or organization to exclusively profit from the “invention” or deny others the ability to exploit the invention for their own profit.

It brings up the obvious question here: Why would the U.S. government claim to have “invented” Ebola and then claim an exclusively monopoly over its ownership?

U.S. Government claims exclusive ownership over its “invention” of Ebola

The “SUMMARY OF THE INVENTION” section of the patent document also clearly claims that the U.S. government is claiming “ownership” over all Ebola viruses that share as little as 70% similarity with the Ebola it “invented”:

…invention relates to the isolated EboBun virus that morphologically and phylogenetically relates to known members filoviridae… In another aspect, the invention provides an isolated hEbola EboBun virus comprising a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence that hybridizes to the sequence set forth in SEQ ID NO: 1 under stringent conditions; and c) a nucleotide sequence that has at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the SEQ ID NO:

1. In another aspect, the invention provides the complete genomic sequence of the hEbola virus EboBun.

Ebola vaccines and propagation

The CDC patent goes on to explain it specifically claims patent protection on a method for propagating the Ebola virus in host cells as well as treating infected hosts with vaccines:

In another aspect, the invention provides a method for propagating the hEbola virus in host cells comprising infecting the host cells with the inventive isolated hEbola virus described above, culturing the host cells to allow the virus to multiply, and harvesting the resulting virions.

In another aspect, the invention provides vaccine preparations, comprising the inventive hEbola virus, including recombinant and chimeric forms of the virus, nucleic acid molecules comprised by the virus, or protein subunits of the virus. The invention also provides a vaccine formulation comprising a therapeutically or prophylactically effective amount of the inventive hEbola virus described above, and a pharmaceutically acceptable carrier.

No medical reason to bring Ebola to the United States

This patent may help explain why Ebola victims are being transported to the United States and put under the medical authority of the CDC. These patients are carrying valuable intellectual property assets in the form of Ebola variants, and the Centers for Disease Control clearly desires to expand its patent portfolio by harvesting, studying and potentially patenting new strains or variants.

Dr. Bob Arnot, an infectious disease specialist who spent time on the ground in developing nations saving lives, recently told Judge Jeanine, “There is no medical reason to bring them here, especially when you see how well Dr. Bradley was.” (2)

There is, however, an entirely different reason to bring Ebola patients to America: so they can be exploited for medical experiments, military bioweapons harvesting or intellectual property claims.

Surely, medical authorities at Emory University and the CDC are working hard to save the lives of the two patients who have been transported to the U.S. But they are also pursuing something else at the same time: an agenda of isolating, identifying and patenting infectious disease agents for reasons that we can only imagine.

Only hoping to save lives?

On one hand, it’s worth pointing out that the CDC’s patent on Ebola is at least partially focused on methods for screening for Ebola and treating Ebola victims with drugs or vaccines. This seems like a worthwhile precaution against an infectious disease that clearly threatens lives.

On the other hand, why the patent? Patenting Ebola seems as odd as trying to patent cancer or diabetes. Why would a government organization claim to have “invented” this infectious disease and then claim a monopoly over its exploitation for commercial use?

Does the CDC hope to collect a royalty on Ebola vaccines? Is it looking to “invent” more variants and patent those too?

Make no mistake that billions of dollars in profits are at stake in all this. Shares of Tekmira surged over 11% last Friday as pressure was placed on the FDA to fast-track Ebola vaccine trials the company has set up. “Health campaigners have started a petition which has already been signed by approximately 15,500 people on change.org pressurizing FDA to approve the drug in the minimum possible time frame,” reports BidnessEtc.com. (3)

Carefully scripted medical theater

With this, we start to see the structure of the elaborate medical theater coming together: A global pandemic panic, a government patent, the importation of Ebola into a major U.S. city, an experimental vaccine, the rise of a little-known pharmaceutical company and a public outcry for the FDA to fast-track the vaccine.

If Act II stays on course, this medical theater might someday involve a “laboratory accident” in a U.S. lab, the “escape” of Ebola into the population, and a mandatory nationwide Ebola vaccination campaign that enriches Tekmira and its investors while positioning the CDC with its virus patents as the “savior of the American people.”

Yes, we’ve heard this music before, but the last time around it was called Swine Flu.

The formula is always the same: create alarm, bring a vaccine to market, then scare governments into buying billions of dollars worth of vaccines they don’t need.

Watch the episode with Judge Jeanine here: